Ticker
AIMCompany Name
AIM IMMUNOTECH INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -15.56M | -12858.68% | $ 121K |
3/31/2025 | $ -14.57M | -9980.14% | $ 146K |
12/31/2024 | $ -16.73M | -9844.12% | $ 170K |
9/30/2024 | $ -23.48M | -12355.79% | $ 190K |
6/30/2024 | $ -27.79M | -13827.86% | $ 201K |
3/31/2024 | $ -31.05M | -16086.01% | $ 193K |
12/31/2023 | $ -28.96M | -14337.62% | $ 202K |
9/30/2023 | $ -20.77M | -10764.25% | $ 193K |
6/30/2023 | $ -19.34M | -11514.29% | $ 168K |
3/31/2023 | $ -19.29M | -12362.82% | $ 156K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for AIM IMMUNOTECH INC is calculated as follows: EBIT [ $ -11.16M ] / Revenues [ $ 171K ]
(=) EBIT % [ -6526.32% ]
Minimum
Mar 31, 2024
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |